The Manufacturers Life Insurance Company Acquires Shares of 257,702 Astera Labs, Inc. $ALAB

The Manufacturers Life Insurance Company bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 257,702 shares of the company’s stock, valued at approximately $124,475,000.

Other hedge funds have also made changes to their positions in the company. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Astera Labs during the fourth quarter worth approximately $18,708,000. Swedbank AB lifted its holdings in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in Astera Labs in the 4th quarter valued at $499,000. Revere Asset Management Inc acquired a new position in Astera Labs in the 4th quarter valued at $589,000. Finally, Banque Cantonale Vaudoise increased its stake in Astera Labs by 85.9% in the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after buying an additional 3,229 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $282.65 on Wednesday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The firm has a market capitalization of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84. The company’s fifty day moving average is $348.88 and its two-hundred day moving average is $247.38.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter last year, the firm posted $0.44 EPS. The business’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently commented on ALAB. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Roth Capital reissued a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Barclays raised their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Rothschild & Co Redburn began coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Finally, Susquehanna boosted their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

Insider Activity at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the completion of the sale, the director directly owned 4,631 shares in the company, valued at approximately $2,083,950. This trade represents a 66.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This trade represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock valued at $163,135,169 in the last ninety days. Company insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.